The U.S. Supreme Court on Tuesday opted not to hear Johnson & Johnson’s talcum powder case, letting stand a $2.1 billion verdict, but the decision is unlikely to have much impact on thousands of similar lawsuits pending in the courts.

The high court declined to take up the petition, which raised constitutional concerns about both the punitive damages in the jury’s 2018 award, and the judge’s move to consolidate into a single trial the claims of 22 women who blamed their ovarian cancer on Johnson & Johnson’s talc products. Johnson & Johnson’s petition also raised jurisdictional concerns, given that 20 of the women weren’t even from Missouri, where the trial took place in 22nd Judicial Circuit Court in St. Louis.